You can buy or sell Insulet and other stocks, options, ETFs, and crypto commission-free!
Insulet Corporation Common Stock, also called Insulet, is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. Read More The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
52 Week High
52 Week Low
Advertising and Marketing
Yahoo FinanceMay 15
Insulet and West Pharma Proven Winners in Growing Wearable Devices Market
- By Barry Cohen With rapid growth projected for the market for wearable drug delivery devices, investors would be wise to consider some of the key players in the business. Two standouts are Boston-area-based Insulet (PODD) and West Pharmaceutical Services (WST), which is headquartered in Exton, Pennsylvania. These companies don't make the drugs. They develop the devices patients wear that deliver the medications. Both firms have rewarded shareholders handsomely. Insulet, which is worth more than...
Yahoo FinanceMay 13
Insulet and Novocure Are Going Gangbusters
Insulet (NASDAQ: PODD) and Novocure (NASDAQ: NVCR) both recently knocked the cover off of the ball in their recent earnings reports.
Expected Aug 1, After Hours